Condition: Alcoholic Liver Disease · Alcohol Use Disorder · Alcohol Abuse · Sponsor: Zealand University Hospital
The goal of this clinical trial is to evaluate the efficacy of screening for liver disease with liver stiffness measurement on abstinence or light consumption after 6 months in individuals who are receiving treatment for alcohol use disorder and without a history of liver disease. The investigators will conduct a randomized controlled trial with concealed allocation comparing A) an invitation to a liver stiffness measurement, blood sampling and leaflet on alcohol-related disease (intervention) with B) an invitation to blood sampling (control). The primary outcome is 'abstinence or light consumption' (≤ 10 units/week) throughout the last months, and assessed 6 months after randomization.
This description comes directly from the study's public registry record.
Pernille Dahlin, MD · +45 30291114 · pedah@regionsjaelland.dk
Gro Askgaard, PHD · gras@regionsjaelland.dk
Always discuss trial participation with your own doctor first.
| Novavi Køge | Køge, Denmark | Recruiting |
| Novavi Roskilde | Roskilde, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05855031